Hepatitis B Virus Therapy
Study results from Eskisehir Osmangazi University, Department of Internal Medicine in the area of hepatitis B virus therapy published
Published in Hepatitis Weekly, April 28th, 2008
New research, 'Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis,' is the subject of a report. According to recent research published in the Journal of Rheumatology, "To evaluate the short-term course of chronic hepatitis B and C under treatment with etanercept (ETN) associated with different disease modifying antirheumatic drugs (DMARD). Patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) receiving anti-tumor necrosis factor-a (TNF-a) were retrospectively reviewed for the presence of hepatitis B or C serology, liver function tests, liver...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-04-28)
More Articles from Hepatitis Weekly
- Antivirals
Findings in antivirals reported from Nagasaki University - Carcinoma
Studies from University of Hong Kong yield new data on carcinoma - Enzyme Research
Study data from National University update understanding of enzyme research - Hematologic Disease
Researchers' work from Ege University, Medical Department focuses on hematologic disease - Hepatitis A Virus
Data on hepatitis A virus described by L. Aragones et al - Hepatitis A Virus
Research from University of Surrey in the area of hepatitis A virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
